The aim of this study is to evaluate same day discharge (SDD), postoperative pain, safety, recovery and cost-effectiveness within 6 weeks after surgery, in woman undergoing two different surgical techniques; VANH or VH
ID
Source
Brief title
Condition
- Obstetric and gynaecological therapeutic procedures
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary objective is the difference in percentage of SDD in both groups.
Secondary outcome
• Complications, severity scored by Clavien-Dindo classification (see
attachment 6)
o Injuries to bowel, bladder, ureter, vessels, nerves
o Thrombo-embolic events
o Haematoma requiring surgical intervention
o Haemorrhage requiring transfusion or surgical intervention
o Wound dehiscence requiring surgical intervention
o Wound infections including vaginal vault abscesses
• Treatment related outcomes
o Conversion rate
o Time in operation room (measured from entering the operating theatre
until leaving the theatre to the recovery)
o Surgery time (start of incision and end of surgical procedure)
o Blood loss (measured in mL)
o Pain measured in numeric rating scale (NRS) at: 1 hours
postoperative, 8 hours postoperative and 24 hours postoperative
o Recovery of pain (measured in NRS) within the first week after
surgery
o Use of analgesics (daily use of paracetamol, NSAIDs, opioids)
o Resumption of daily activity
o Hospital readmission within 6 weeks after surgery
o Post-operative pain the first 7 days after surgery (measured on a
numeric rating scale (NRS))
• Intended number of salpingectomies in each group
• Number of salpingectomies performed in each group
• Recovery index-10 (RI-10) measured on different moments pre- and
post-operative
• Health-related quality of life (EQ-5D-5L questionnaire)
• Costs (including intervention costs, hospital costs, healthcare costs outside
the hospital and costs due to loss of productivity; using an adapted version of
iMCQ questionnaire) (see attachment 5 and 8).
• Cost-effectiveness (of VANH versus VH)
Background summary
The hysterectomy is one of the most performed gynaecological surgeries
worldwide [2, 3].
In the Netherlands about 14.500 hysterectomies are performed yearly [4]. The
most common benign indications to perform a hysterectomy are abnormal uterine
bleeding, uterine leiomyomas, endometriosis or adenomyosis, chronic pelvic
pain, uterine prolapse, benign ovarian neoplasm, hyperplasia or atypia of the
endometrium or cervical dysplasia [5-7].
The four approaches to perform a hysterectomy for benign disease are
abdominal hysterectomy (AH), vaginal hysterectomy (VH),
laparoscopic hysterectomy (LH) and robotic-assisted hysterectomy (RH) [3, 8].
VH appears to be superior to the AH, resulting in a quicker recovery [5]. The
LH results in a quicker recovery than the AH and VH, but increases the risks of
damage to the bladder or ureter [5]. That is why a recent Cochrane review
advises to perform a VH when feasible for women undergoing a hysterectomy for a
benign indication [5]. When VH is technically not feasible, a LH or AH is
performed. LH resulted in more rapid recovery, fewer febrile episodes and less
wound complications compared to AH [5]. The RH is not superior compared to the
LH and is associated with higher costs [10].
Since the introduction of laparoscopy, the VH and AH decreased and the rate of
LH significantly increased between 2002 and 2012 [9]. Performing a LH gives the
opportunity to inspect the abdominal cavity and to easily perform an
opportunistic salpingectomy compared to VH [10]. An opportunistic salpingectomy
during a hysterectomy for benign indication might reduce the overall risk of
ovarian cancer [11].
Additionally, patients experience less postoperative pain after a LH compared
to a VH and therefore need less post-operative pain medication [10]. Advantages
of the VH compared to the LH are a shorter operation duration, no visible scars
and a lower chance of dehiscence of the vaginal cuff [10].
In 2004, a novel approach of endoscopic surgery was described, *Natural Orifice
Transluminal Endoscopic Surgery (NOTES) by researchers at the John Hopkins
University [12]. It is a surgical technique using natural orifices of the body
(e.g. mouth, anus, urethra, vagina) to perform scarless surgery [13]. The
vaginal approach is called the vNOTES technique. NOTES is an emerging field
within minimal access surgery, evolves and presents multiple possibilities for
innovation and development. The initial approach was trans gastric, but
subsequently, NOTES has been evolved, resulting in trans rectal, trans gastric,
transvaginal, and transurethral approaches nowadays [14-16].
In 2012, the first vNOTES hysterectomy, also called vaginal assisted NOTES
hysterectomy (VANH) was performed [17]. vNOTES surgery can be used for
different indications, for example hysterectomy, adnexectomy, tubectomy or
salpingectomy in case of an ectopic pregnancy [18].
In 2018, the first randomised controlled trial (RCT) comparing TLH with VANH in
70 women was published [1]. This HALON trial showed VANH was non-inferior to
TLH [1]. Compared to TLH, surgery time was significantly shorter, patients
experience less post-operative pain and same day discharge (SDD) was possible
in 77% of the women who underwent the VANH compared to 43% after TLH [1].
Besides, the VANH showed less post-operative complications [1].
Except for the HALON trial and two retrospective studies [19, 20] and
case-control studies [21, 22] there is little literature about VANH.
No studies have been performed comparing the VH with the VANH. Because the VH
is the preferred method to perform a hysterectomy for a benign indication [23],
there is a need to compare VH with VANH and to explore the indications to
perform a VANH.
Study objective
The aim of this study is to evaluate same day discharge (SDD), postoperative
pain, safety, recovery and cost-effectiveness within 6 weeks after surgery, in
woman undergoing two different surgical techniques; VANH or VH
Study design
The design of this study is a single-blind, multicentre, randomised controlled
trial (RCT). Eligible patients will be randomised in either the VH group and
receive a vaginal hysterectomy or in the VANH-group and the hysterectomy is
performed by vaginal assisted NOTES surgery.
Intervention
VANH-hysterectomy
All planned VANH hysterectomies are scheduled in the morning before 12.00u pm.
All VANH procedures will be performed by surgeons who have the skills to
perform a VANH. This means that the surgeons will be experiences in performing
a VANH and must have performed at least 25 VANH independently, as it is
demonstrated that he learning curve consists of 25 cases [28].
Elective salpingectomy will be performed after counselling on the outpatient
clinic, subsequently on patients request. Pre-operative cefazolin 2 gram and
500 mg metronidazole is administered intravenously.
The patient is placed in lithotomy position. After disinfection and sterile
draping, a urinary bladder catheter is inserted into the bladder. At start of
the procedure descensus uteri will be classified according to the
POPQ-classification.
Access to the peritoneal cavity will be performed similar to vaginal surgery by
a circular incision around the cervix, anterior and posterior colpotomy and
transsecting the sacro-uterine ligaments.
The vNOTES port (GelPOINT V-Path, Applied Medical) will be placed to get access
to the abdominal cavity and a pneumoperitoneum will be created. After
positioning in 20o degree Trendelenburg laparoscopic instruments will be
introduced (30o laparoscope, a grasping forceps and sealing device through
three trocars). The peritoneal cavity and ureters are inspected. The
hysterectomy is performed by dissecting from caudally to cranially. The
fallopian tubes will be removed elective after counselling in the outpatient
clinic and the ovaries will be removed on indication only.
Finally, haemostasis is checked and the vNOTES port and the uterus are removed
trans-vaginally and the pneumoperitoneum is deflated. The vaginal cuff will be
closed using a running Vicryl-1 suture. The urinary bladder catheter will be
removed directly postoperative.
Study burden and risks
vNOTES is a new surgical technique, but a combination of two existing
techniques namely the vaginal hysterectomy and the laparoscopic hysterectomy.
Only one randomized controlled trial has been published, comparing the total
laparoscopic hysterectomy with the VANH, which shows no inferiority of the
vNOTES technique compared to the TLH. A recent case series study has been
published about the complication rate in VANH. There was a total complication
rate in the hysterectomy group of 5.2%, in which 1.4% was intra-operative and
3.8% postoperative. Theoretically it is possible that the VANH causes less
intra-operative complications because of an improved view during the
procedure. No further literature is known about VH versus VANH. Participants
of the study should fill in multiple questionnaires before randomization and
postoperative about their general health, pain experience and used analgesics.
Henri Dunantstraat 5
Heerlen 6419PC
NL
Henri Dunantstraat 5
Heerlen 6419PC
NL
Listed location countries
Age
Inclusion criteria
- Written and orally given informed consent
- 18 years and older
- Native Dutch speaker or in control of the Dutch language in speaking and
writing
- Indication for hysterectomy for benign indication
- Possible to perform a VH judged by experienced (resident) gynaecologist
during gynaecological examination
Exclusion criteria
- Any contra-indication for VH (for example, large uterus myomatosus, not
enough descensus, etc) as judged by experienced gynaecologist
- Contra-indication for general anaesthesia
- History of more than 1 caesarean section
- History of endometriosis
- History of rectal surgery
- History of pelvic radiation
- Suspected rectovaginal endometriosis
- History of pelvic inflammatory disease, especially prior tubo-ovarian or
pouch of Douglas abscess or suspected adhesions due to (ruptured) inflammatory
disease (for example ruptured appendicitis)
- Virginity
- Pregnancy
- Indication for anterior or posterior colporrhaphy during the same surgery
- Indication of mid urethral slings
- Uterus myomatosus will not be an exclusion criteria but the surgeon will
indicate if it is possible to remove the uterus vaginally.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL76240.096.21 |